Savara Inc (SVRA):企業の財務・戦略的SWOT分析

◆英語タイトル:Savara Inc (SVRA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME185401FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥33,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥49,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Savara Inc (SVRA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Savara Inc (Savara), formerly Mast Therapeutics Inc, is a clinical stage biopharmaceutical company, which develops therapies for the treatment of rare respiratory diseases, including cystic fibrosis (CF), and pulmonary alveolar proteinosis (PAP). The company’s lead product candidates include Molgradex, an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment of treatment of PAP; and AeroVanc, an inhaled formulation of vancomycin for the treatment of CF. The company has subsidiaries in the US and Denmark. Savara is headquartered in Austin, Texas, the US.

Savara Inc Key Recent Developments

Dec 10,2020: Savara provides pipeline and business update
Nov 05,2020: Savara reports third quarter 2020 financial results and provides business update
Sep 11,2020: Savara announces Senior Management Changes
Aug 06,2020: Savara reports second quarter 2020 financial results and provides business update
May 27,2020: SAVARA: Election of directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Savara Inc – Key Facts
Savara Inc – Key Employees
Savara Inc – Key Employee Biographies
Savara Inc – Major Products and Services
Savara Inc – History
Savara Inc – Company Statement
Savara Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Savara Inc – Business Description
R&D Overview
Savara Inc – SWOT Analysis
SWOT Analysis – Overview
Savara Inc – Strengths
Savara Inc – Weaknesses
Savara Inc – Opportunities
Savara Inc – Threats
Savara Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Savara Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Savara Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Savara Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 10, 2020: Savara provides pipeline and business update
Nov 05, 2020: Savara reports third quarter 2020 financial results and provides business update
Sep 11, 2020: Savara announces Senior Management Changes
Aug 06, 2020: Savara reports second quarter 2020 financial results and provides business update
May 27, 2020: SAVARA: Election of directors
May 07, 2020: Savara reports first quarter 2020 financial results and provides business update
Mar 30, 2020: Savara provides business update in response to COVID-19 pandemic
Mar 12, 2020: Savara reports fourth quarter / year-end 2019 financial results and provides business update
Dec 03, 2019: Savara announces the appointment of Dr. An van Es-Johansson to board of directors
Nov 07, 2019: Savara reports third quarter 2019 financial results and provides business update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Savara Inc, Key Facts
Savara Inc, Key Employees
Savara Inc, Key Employee Biographies
Savara Inc, Major Products and Services
Savara Inc, History
Savara Inc, Subsidiaries
Savara Inc, Key Competitors
Savara Inc, Ratios based on current share price
Savara Inc, Annual Ratios
Savara Inc, Annual Ratios (Cont...1)
Savara Inc, Interim Ratios
Savara Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Savara Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Savara Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Savara Inc (SVRA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Enerjisa Enerji AS (ENJSA):企業の財務・戦略的SWOT分析
    Enerjisa Enerji AS (ENJSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • AzurRx BioPharma Inc (AZRX):製薬・医療:M&Aディール及び事業提携情報
    Summary AzurRx BioPharma Inc (AzurRx BioPharma) is a development stage biopharmaceutical company that research and develops non-systemic biologics for the treatment of patients with gastrointestinal disorders. The company’s products under development include MS1819, a non-systemic yeast recombinant …
  • A.P. Moller – Maersk AS Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    A.P. Moller - Maersk AS Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary A.P. Moller - Maersk AS (APM) is an integrated transport and logistics company with operations in container shipping and ports operating through a subsidiary and affiliates. It transports dry …
  • Castle Brands Inc.:企業の戦略・SWOT・財務情報
    Castle Brands Inc. - Strategy, SWOT and Corporate Finance Report Summary Castle Brands Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Heptares Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Heptares Therapeutics Ltd (Heptares), a subsidiary of Sosei Group Corp is a drug discovery company that develops small-molecule drugs. The company develops drugs for targeting G-protein-coupled receptors by utilizing its drug discovery technology platforms. Its technology platforms comprise …
  • PolyOne Corporation:企業の戦略・SWOT・財務情報
    PolyOne Corporation - Strategy, SWOT and Corporate Finance Report Summary PolyOne Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Rosoboronexport:戦略・SWOT・企業財務分析
    Rosoboronexport - Strategy, SWOT and Corporate Finance Report Summary Rosoboronexport - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SAS AB:戦略・SWOT・企業財務分析
    SAS AB - Strategy, SWOT and Corporate Finance Report Summary SAS AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Western & Southern Financial Group, Inc.:戦略・SWOT・企業財務分析
    Western & Southern Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Western & Southern Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • J. Front Retailing Co., Ltd.:戦略・SWOT・企業財務分析
    J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Novacyt SA (ALNOV):企業の製品パイプライン分析2018
    Summary Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt deve …
  • Crown Bioscience Inc (6554):製薬・医療:M&Aディール及び事業提携情報
    Summary Crown Bioscience Inc (Crown Bioscience) is a drug discovery company that provides drug discovery and development services. The company offers antibodies, proteins, cell lines, tumor samples, in vivo and in vitro research reagents. It offers services such as preclinical research services, onc …
  • Heinzel Holding GmbH:企業の戦略的SWOT分析
    Heinzel Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • China Construction Bank Corp:企業の戦略・SWOT・財務分析
    China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report Summary China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Alta Mesa Resources Inc:企業の戦略的SWOT分析
    Alta Mesa Resources Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • SBM Offshore NV (SBMO):企業の財務・戦略的SWOT分析
    SBM Offshore NV (SBMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CSG Systems International Inc (CSGS):企業の財務・戦略的SWOT分析
    CSG Systems International Inc (CSGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • AZTherapies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary AZTherapies Inc (AZTherapies) is a clinical-stage drug development company that offers discovery, development and commercialization of novel Alzheimer’s disease therapeutics. The company’s product pipeline includes the lead product candidate ALZT-OP1, besides ALZT-Patch, ALZT-QoL, AZHALER-D …
  • Corpak MedSystems Inc-医療機器分野:企業M&A・提携分析
    Summary Corpak MedSystems Inc (Corpak), a subsidiary of Halyard Health Inc is a medical device company that manufactures and markets enteral feeding safety devices. The company offers products such as cortrak systems, gastrostomy, nasoenteric systems, gastric decompression, NICU products and accesso …
  • Phillips 66 Co (PSX)-石油・ガス分野:企業M&A・提携分析
    Summary Phillips 66 Company (Phillips 66) is a diversified energy manufacturing and logistics company. It gathers, processes, transports and markets natural gas and petroleum products such as gasoline, diesel, aviation fuel and lubricants, and transports, fractionates and markets natural gas liquids …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆